Acne remedies and ADHD drugs are big markets for the teen demographic — but how exactly are young consumers interpreting advertisements for these products? A soon-to-launch FDA study aims to find out exactly that.
The Centers for Medicare & Medicaid Services propose 4 changes to physician payment transparency rules that could mean major new costs for medical device makers.
UPS has ramped up its healthcare-compliant delivery service for the medical device industry, claiming it can now deliver products within four hours to more than 80% of the hospital beds in the U.S. from its network of Field Stocking Locations.
New York City is the center of the world’s largest economy, home to some banner medical institutions and a hotbed of global financiers. However, the city has never evolved into the biotech hotbed local leaders have hoped to see, a failure largely due to one of its inescapable traits: high rent.
Spending on MedTech Steady at Six Percent of U.S. Health Expenditures: Medical technology prices continue their trend of consistently low growth, increasing at approximately one-third the rate of prices in the overall economy and one-fifth the rate of prices for other medical goods and services over a 23-year period, according to an updated study released today by the Advanced Medical Technology Association (AdvaMed).
Each year, thousands of Americans are diagnosed with some form of skin cancer. The Surgeon General’s Call to Action to prevent skin cancer is important especially during these hot summer months when many of us spend extra time in the sun.
Last year, antibiotic-resistant infections caused more than two million illnesses and 23,000 deaths in the U.S. alone, according to the Centers for Disease Control. About 70 percent of those antibiotic-resistant infections were caused by hospital-acquired infections.
Senator Seeks Transparency in Medical Device Pricing
A new report predicts that the global in vitro diagnostics market will grow to $74.7 billion by 2020 fueled by increased awareness and demand for equipment that speeds up accurate diagnosis.
The US Food and Drug Administration (FDA) plans to pour as much as $37.5 million into an initiative intended to improve the quality of clinical trials, the agency has announced.